Ekugcineni sizovalelisa ku-Alzheimer's futhi kungase kube yisikhathi esidlule

Ekugcineni sizovalelisa ku-Alzheimer's futhi kungase kube yisikhathi esidlule

Ngethemba lokuthi ukubambezeleka kwalesi sifo kuzoba yisiqalo sensindiso kuso, i-US Food and Drug Administration (FDA) inikeze, ngoLwesine, ukugunyazwa kwayo okugcwele kokusetshenziswa kwesidakamizwa esithi "Leqembi" ezigulini ze-Alzheimer's.

Futhi i-ejensi ithe umuthi uwumuthi wokuqala obonakale uphumelela ekubambezeleni ukuqhubeka kwesifo esiphuca inkumbulo, ngokusho kwabikwa yinethiwekhi ye-American "CNN".

Ukwelashwa okuphephile nokusebenzayo

Ukugunyazwa kulindeleke ukuthi kufake isandla ekushintsheni ubukhulu bomshwalense wezempilo ohlinzekwa nguhulumeni ngokusebenzisa izinsiza ze-“Medicare” kanye ne-“Medicaid”, ezingaba nomthelela ekufakweni kwezigidi zabantu abahlala ezigabeni zokuqala zalokhu. isifo.

I-FDA esitatimendeni ithe isinqumo sayo siyisiqiniseko sokuqala sokuthi umuthi oqondiswe ekuqhubekeleni phambili kwesifo i-Alzheimer ukhombise izinzuzo zokwelapha lesi sifo esibhubhisayo.

Wengeze ngokuthi ucwaningo olufakazelwe luqinisekisa ukuthi luyindlela yokwelapha ephephile nesebenzayo ezigulini ze-Alzheimer's.

Lokhu kwenzeke ngemuva kokuthi i-Liquimbe ikhombise ukusebenza kahle kwayo ovivinyweni lomtholampilo lwezinyanga eziyi-18 ngokunciphisa ukwehla kwengqondo nokusebenza ngama-27%.

Ngokulandelayo, uDkt. Lawrence Honig, uProfesa Wesayensi Yezinzwa e-Columbia University, waphakamisa ukuthi ikilasi labahlomula izidakamizwa cishe liyingxenye eyodwa kwesithupha kwabaseMelika abayizigidi eziyisithupha abanalesi sifo.

"Sisekuqaleni kwenkathi entsha," kusho uprofesa, engxoxweni ne-American Network, egcizelela ukuthi umuthi awukwazi ukwelapha iziguli, kodwa kunalokho usiza ekubambezeleni ukukhula kwesifo sabo, okubonisa ukuthi unethemba lokuthi sizophumelela. ukwazi ukuthola imithi esebenza ngempumelelo.

Ukugunyaza okusheshayo

Isidakamizwa esithi "Liquimbe", esikhiqizwa izinkampani "i-Eisai" ne "Biogen", sathola ukugunyazwa okusheshayo ngoJanuwari odlule, ngokusekelwe ebufakazini obufakazela impumelelo yaso ekukhipheni ukuqoqwa kwe-amyloid protein deposits ebuchosheni obubhekene nesifo i-Alzheimer's.

Futhi “i-FDA” igunyaze umuthi kubantu abadlula ezigabeni zokuqala zesifo i-Alzheimer’s, kanye nalabo abahlushwa ubunzima obuncane bokuqonda kanye nalabo abaye bafakazela ama-amyloid deposits ebuchosheni babo.

Ngaphezu kwalokho, inethiwekhi iphawule ukuthi umuthi awunayo imiphumela emibi, njengoba cishe i-13% yalabo abangaphansi kokuhlolwa komtholampilo bahlushwa ukopha noma ukukhuliswa kwengqondo, futhi lezi zimpawu zingase zibe yingozi enkulu kwamanye amaqembu ngokwezakhi zawo zofuzo. noma uma bethatha imithi enciphisa igazi.

Izibikezelo ze-horoscope zika-Maguy Farah zonyaka ka-2023